PMA supplement
P890055 S092: lntera 3000 Hepatic Artery Infusion Pump
FDA PMA supplement · Real-Time Process · Intera Oncology
Key facts
| Original PMA | P890055 |
|---|---|
| Supplement number | S092 |
| Supplement type | Real-Time Process |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | lntera 3000 Hepatic Artery Infusion Pump |
| Generic name | Pump, infusion, implanted, programmable |
| Applicant | Intera Oncology |
| Product code | LKK |
| Received date | Nov 26, 2025 |
| Decision date | Feb 26, 2026 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: